J P Bilezikian, C J F Lin, J P Brown, A T Wang, X Yin, P R Ebeling, A Fahrleitner-Pammer, E Franek, N Gilchrist, P D Miller, J A Simon, I Valter, C A F Zerbini, C Libanati, A Chines
Upper limb fractures (including wrist, forearm, and humerus) represent a significant burden among postmenopausal women with osteoporosis. Up to 7 years of treatment with denosumab resulted in an increase in bone mineral density and decrease in fractures in upper limb sites. INTRODUCTION: Upper limb (wrist, forearm, and humerus) fractures are a significant burden in osteoporosis, associated with significant morbidity and mortality. Denosumab, a monoclonal antibody against RANK ligand, increases bone mineral density (BMD) and decreases vertebral, nonvertebral, and hip fractures...
September 2019: Osteoporosis International